Citation: Ig. Levy et al., PROSTATE-CANCER - 1 - THE DESCRIPTIVE EPIDEMIOLOGY IN CANADA, CMAJ. Canadian Medical Association journal, 159(5), 1998, pp. 509-513
Authors:
GLEAVE ME
ELHILALI M
FRADET Y
DAVIS I
VENNER P
SAAD F
KLOTZ LH
MOORE MJ
PATON V
BAJAMONDE A
Citation: Me. Gleave et al., INTERFERON GAMMA-1B COMPARED WITH PLACEBO IN METASTATIC RENAL-CELL CARCINOMA, The New England journal of medicine, 338(18), 1998, pp. 1265-1271
Citation: J. Tsihlias et al., GROWTH ARREST OF LNCAP HUMAN PROSTATE-CANCER CELLS BY HIGH-DOSE DIHYDROTESTOSTERONE - EFFECT OF CELL-PROLIFERATION AND CHANGES IN THE CELL-CYCLE REGULATORY PROTEINS, The Journal of urology, 159(5), 1998, pp. 32-32
Authors:
BRUCHOVSKY N
KLOTZ LH
CROOK JM
ARMITAGE GR
GLEAVE ME
GOLDENBERG SL
Citation: N. Bruchovsky et al., A PHASE-II STUDY OF INTERMITTENT ANDROGEN SUPPRESSION (IAS) IN MEN WITH A RISING SERUM PSA AFTER RADIATION FOR LOCALIZED PROSTATE-CANCER, The Journal of urology, 159(5), 1998, pp. 1287-1287
Citation: F. Rabbani et al., PREDICTORS OF PATHOLOGICAL STAGE BEFORE NEOADJUVANT ANDROGEN WITHDRAWAL THERAPY AND RADICAL PROSTATECTOMY, The Journal of urology, 159(3), 1998, pp. 925-928
Authors:
ZHANG WB
KAPUSTA LR
SLINGERLAND JM
KLOTZ LH
Citation: Wb. Zhang et al., TELOMERASE ACTIVITY IN PROSTATE-CANCER, PROSTATIC INTRAEPITHELIAL NEOPLASIA, AND BENIGN PROSTATIC EPITHELIUM, Cancer research, 58(4), 1998, pp. 619-621
Authors:
TSIHLIAS J
KAPUSTA LR
DEBOER G
MORAVAPROTZNER I
ZBIERANOWSKI I
BHATTACHARYA N
CATZAVELOS GC
KLOTZ LH
SLINGERLAND JM
Citation: J. Tsihlias et al., LOSS OF CYCLIN-DEPENDENT KINASE INHIBITOR P27(KIP1) IS A NOVEL PROGNOSTIC FACTOR IN LOCALIZED HUMAN PROSTATE ADENOCARCINOMA, Cancer research, 58(3), 1998, pp. 542-548
Authors:
NAM RK
KLOTZ LH
JEWETT MAS
DANJOUX C
TRACHTENBERG J
Citation: Rk. Nam et al., PROSTATE-SPECIFIC ANTIGEN VELOCITY AS A MEASURE OF THE NATURAL-HISTORY OF PROSTATE-CANCER - DEFINING A RAPID RISER SUBSET, British Journal of Urology, 81(1), 1998, pp. 100-104
Citation: Ga. Dijkman et al., CLINICAL-EXPERIENCES OF VISUAL DISTURBANCES WITH NILUTAMIDE - COMMENT, The Annals of pharmacotherapy, 31(12), 1997, pp. 1550-1551
Authors:
GOLDENBERG SL
KLOTZ LH
SRIGLEY J
JEWETT MAS
MADOR D
FRADET Y
BARKIN J
CHIN J
PAQUIN JM
BULLOCK MJ
LAPLANTE S
Citation: Sl. Goldenberg et al., RANDOMIZED, PROSPECTIVE, CONTROLLED-STUDY COMPARING RADICAL PROSTATECTOMY ALONE AND NEOADJUVANT ANDROGEN WITHDRAWAL IN THE TREATMENT OF LOCALIZED PROSTATE-CANCER - REPLY, The Journal of urology, 157(3), 1997, pp. 965-965
Authors:
ELHILALI MM
RAMSEY EW
BARKIN J
CASEY RW
BOAKE RC
BELAND G
FRADET Y
TRACHTENBERG J
OROVAN WL
SCHICK E
KLOTZ LH
Citation: Mm. Elhilali et al., A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TERAZOSIN IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA, Urology, 47(3), 1996, pp. 335-342
Authors:
GOLDENBERG SL
KLOTZ LH
SRIGLEY J
JEWETT MAS
MADOR D
FRADET Y
BARKIN J
CHIN J
PAQUIN JM
BULLOCK MJ
SULLIVAN LD
GLEAVE ME
MCLOUGHLIN MG
PRESTAGE K
KINAHAN TJ
OROVAN WL
WHELAN JP
HERSCHORN S
KERESTECI AG
ROBINETTE M
BRUCE A
STEWART DA
RUETHER JD
ERNST DS
CHETNER M
METCALFE JB
ELHILALI M
APRIKIAN AG
BERTRAND PE
SCHICK E
TESSIER J
HALSALL AK
WECKWORTH PF
Citation: Sl. Goldenberg et al., RANDOMIZED, PROSPECTIVE, CONTROLLED-STUDY COMPARING RADICAL PROSTATECTOMY ALONE AND NEOADJUVANT ANDROGEN WITHDRAWAL IN THE TREATMENT OF LOCALIZED PROSTATE-CANCER, The Journal of urology, 156(3), 1996, pp. 873-877
Citation: Ph. Pinkerton et Lh. Klotz, TRANSFUSION PRACTICE IN UROLOGICAL SURGERY - MODIFICATIONS IN ASSOCIATION WITH THE INTRODUCTION OF AN AUTOLOGOUS BLOOD-DONOR PROGRAM, TRANSFUSION MEDICINE, 5(1), 1995, pp. 69-73